1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Solanbridge Group, Inc.

Solanbridge Group, Inc.

SLNX
Solanbridge Group, Inc.US flagOther OTC
0.00
USD
- -
- -
476,000.00Market Cap

Total Valuation

Solanbridge Group, Inc. carries a market capitalization of 476,000.00, placing it among publicly traded companies globally.

Market Cap476,000.00
Enterprise ValueN/A

Share Statistics

Solanbridge Group, Inc. currently has 15.46M shares outstanding.

Shares Outstanding15.46M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio-0.43
P/TBV Ratio-1.37
P/FCF Ratio-3.42
P/OCF Ratio-3.42

Financial Position

Current RatioN/A
Quick RatioN/A
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage-1.37

Stock Price Statistics

Solanbridge Group, Inc.'s stock has gained approximately 400.00003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Beta (5Y)N/A
52-Week Price Change400.00003%
50-Day Moving Average0.00
200-Day Moving Average0.00
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -174,636.00, while operating income came in at -174,636.00.

RevenueN/A
Gross ProfitN/A
Operating Income-174,636.00
Pretax Income-301,822.00
Net Income-301,822.00
EBITDA-174,636.00
EBIT-174,636.00
Earnings Per Share (EPS)-0.02

Balance Sheet

Total book value stands at -1.25M, with working capital of -395,723.00 providing operational flexibility.

Cash & Cash EquivalentsN/A
Total DebtN/A
Net Debt141,100.00
Equity (Book Value)-1.25M
Book Value Per Share-0.08
Working Capital-395,723.00

Cash Flow

Solanbridge Group, Inc. produced -158,300.00 in operating cash flow over the past twelve months.

Operating Cash Flow-158,300.00
Capital ExpendituresN/A
Free Cash Flow-158,300.00
FCF Per Share-0.01

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-29.26
FCF Yield-29.26